| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Chen,Wan-Fu | Chairman | 4.42% | |
| Wang,Yong-Chi | Director | 3.06% | |
| Huang,Su-Ya | Director | 1.70% | |
| Li,Chao-Qin | Director | 0.43% | |
| Chen,Bing-Hong | Independent Director | 0.00% | |
| Shi,Ji-Chang | Independent Director | 0.00% | |
| Yu,Shi-Di | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 1,460,251 | 2,855,271 | 3,125,096 |
| Operating cost | 1,219,833 | 2,503,964 | 2,814,327 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 240,418 | 351,307 | 310,769 |
| Unrealized profit (loss) on sales of goods | 0 | 0 | 0 |
| Realized profit (loss) on sales of goods | - | 0 | 328 |
| Operating gross profit (loss), net | 240,418 | 351,307 | 311,097 |
| Operating expenses | 107,289 | 201,530 | 174,889 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 133,129 | 149,777 | 136,208 |
| Non-operating income and expenses | 4,782 | -8,372 | -11,809 |
| Net profit (loss) before tax | 137,911 | 141,405 | 124,399 |
| Income tax expense (benefits) | 57,031 | 49,975 | 39,953 |
| Net profit (loss) of ongoing business for the current period | 80,880 | 91,430 | 84,446 |
| Profit (loss) of closed units | 0 | -1,044 | 684 |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 80,880 | 90,386 | 85,130 |
| Other comprehensive profit (loss), net | 19,217 | -4,252 | 3,026 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 100,097 | 86,134 | 88,156 |
| Net profit (loss) attributable to owners of parent company | 57,317 | 54,065 | 60,738 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 23,563 | 36,321 | 24,392 |
| Comprehensive profit (loss) attributable to owners of parent company | 74,172 | 50,165 | 63,860 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 25,925 | 35,969 | 24,296 |
| Basic earnings per share (yuan) | 1 | 1 | 1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 165,375 | 304,714 | 118,768 |
| Net cash inflows (outflows) from investing activities | -79,611 | -94,206 | -8,800 |
| Net cash inflow (outflow) from financing activities | 9,772 | -244,660 | -69,783 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 20,496 | -5,826 | 3,188 |
| Increase (decrease) in cash and cash equivalents in the current period | 116,032 | -39,978 | 43,373 |
| Beginning balance of cash and cash equivalents | 382,614 | 422,592 | 379,219 |
| Ending balance of cash and cash equivalents | 498,646 | 382,614 | 422,592 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 2,263,845 | 2,220,316 | 2,377,599 |
| Non-current asset | 683,834 | 594,566 | 607,862 |
| Total asset | 2,947,679 | 2,814,882 | 2,985,461 |
| Current liability | 1,809,226 | 1,780,475 | 1,987,350 |
| Non-current liability | 398,081 | 333,895 | 357,297 |
| Total liability | 2,207,307 | 2,114,370 | 2,344,647 |
| share capital | 332,070 | 332,070 | 332,070 |
| Equity - secruity token | - | - | - |
| capital reserve | 75,644 | 75,844 | 75,844 |
| retained earning | 208,653 | 191,184 | 152,845 |
| Other equity | -16,937 | -33,792 | -29,015 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 599,430 | 565,306 | 531,744 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 140,942 | 135,206 | 109,070 |
| Total Equity | 740,372 | 700,512 | 640,814 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 18 | 17 | 16 |
Return deposit
2014
Pay for the goods
2017
Pay for the project
2017, 2021
Promissory note ruling
2019
Compensation for damage
2015
Allotment Objection Appeal
2021
Pay construction fees, etc.
2020
Confirmation of the existence of employment relationship, etc
2016, 2017
Pay off debt
2018
Payment order
2013, 2016, 2017, 2018
Return deposit
2014
Execution approval
2012, 2013
Pay for the project
2006, 2012, 2013, 2015, 2016, 2018, 2020, 2021, 2022, 2024
Promissory note ruling
2019
Service by publication
2012
Pay contract remuneration
2013, 2014
Allotment Objection Appeal
2022
Pay construction fees, etc.
2020
Request for construction payment
2018, 2019, 2023
Commercial Arbitration Enforcement Ruling
2013
